Publication:
The interplay between viperin antiviral activity, lipid droplets and junin mammarenavirus multiplication

dc.contributor.coauthorPena Carcamo, Jose R.
dc.contributor.coauthorMorell, Maria L.
dc.contributor.coauthorVazquez, Cecilia A.
dc.contributor.coauthorUpadhyay, Arunkumar S.
dc.contributor.coauthorOverby, Anna K.
dc.contributor.coauthorCordo, Sandra M.
dc.contributor.coauthorGarcia, Cybele C.
dc.contributor.kuauthorVatansever, Sezen
dc.contributor.kuprofilePhD Student
dc.contributor.schoolcollegeinstituteGraduate School of Sciences and Engineering
dc.contributor.yokidN/A
dc.date.accessioned2024-11-09T23:21:28Z
dc.date.issued2018
dc.description.abstractJunin arenavirus infections are associated with high levels of interferons in both severe and fatal cases. Upon Junin virus (JUNV) infection a cell signaling cascade initiates, that ultimately attempts to limit viral replication and prevent infection progression through the expression of host antiviral proteins. The interferon stimulated gene (ISG) viperin has drawn our attention as it has been highlighted as an important antiviral protein against several viral infections. The studies of the mechanistic actions of viperin have described important functional domains relating its antiviral and immune-modulating actions through cellular lipid structures. In line with this, through silencing and overexpression approaches, we have identified viperin as an antiviral ISG against JUNV. In addition, we found that lipid droplet structures are modulated during JUNV infection, suggesting its relevance for proper virus multiplication. Furthermore, our confocal microscopy images, bioinformatics and functional results also revealed viperin-JUNV protein interactions that might be participating in this antiviral pathway at lipid droplet level. Altogether, these results will help to better understand the factors mediating innate immunity in arenavirus infection and may lead to the development of pharmacological agents that can boost their effectiveness thereby leading to new treatments for this viral disease.
dc.description.indexedbyWoS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.openaccessYES
dc.description.publisherscopeInternational
dc.description.sponsorshipUniversidad de Buenos Aires (UBA) [20020120100033]
dc.description.sponsorshipConsejo Nacional de Investigaciones Cientificas y Tecnologicas (CONICET) [PIP-0293]
dc.description.sponsorshipAgencia de Promotion Cientifica y Tecnologica (ANPCyT) [BID-PICT 517]
dc.description.sponsorshipCompany of Biologists Limited-Travelling Fellowships Program This study was supported by Universidad de Buenos Aires (UBA) (20020120100033), Consejo Nacional de Investigaciones Cientificas y Tecnologicas (CONICET) (PIP-0293) and Agencia de Promotion Cientifica y Tecnologica (ANPCyT) (BID-PICT 517). S.M.C and C.C.G are members of the Research Career CONICET, J.R.P.C and C.A.V are CONICET fellows and M.L.M is a doctoral fellow of UBA. J.R.P.C has received funds from The Company of Biologists Limited-Travelling Fellowships Program.
dc.description.volume514
dc.identifier.doi10.1016/j.virol.2017.10.012
dc.identifier.issn0042-6822
dc.identifier.quartileQ2
dc.identifier.scopus2-s2.0-85035784306
dc.identifier.urihttp://dx.doi.org/10.1016/j.virol.2017.10.012
dc.identifier.urihttps://hdl.handle.net/20.500.14288/10877
dc.identifier.wos423010200024
dc.keywordsJunin virus
dc.keywordsViperin
dc.keywordsLipids droplets interferon inducible protein
dc.keywordsVirus replication
dc.keywordsSignal peptide
dc.keywordsNew-world
dc.keywordsRIG-I
dc.keywordsBodies
dc.keywordsInhibition
dc.keywordsNucleoprotein
dc.keywordsLocalization
dc.keywordsGlycoprotein
dc.languageEnglish
dc.publisherElsevier
dc.sourceVirology
dc.subjectVirology
dc.titleThe interplay between viperin antiviral activity, lipid droplets and junin mammarenavirus multiplication
dc.typeJournal Article
dspace.entity.typePublication
local.contributor.authorid0000-0002-2745-9618
local.contributor.kuauthorVatansever, Sezen

Files